Literature DB >> 17214964

PARP1 Val762Ala polymorphism reduces enzymatic activity.

Xiao-Gan Wang1, Zhao-Qi Wang, Wei-Min Tong, Yan Shen.   

Abstract

Poly(ADP-ribose) polymerase 1 (PARP1) modifies a variety of nuclear proteins by poly(ADP-ribosyl)ation, and plays diverse roles in molecular and cellular processes. A common PARP1 single nucleotide polymorphism (SNP) at codon 762, resulting in the substitution of alanine (Ala) for valine (Val) in the catalytic domain has been implicated in susceptibility to cancer. To characterize the functional effect of this polymorphism on PARP1, we performed in vitro enzymatic analysis on PARP1-Ala762 and PARP1-Val762. We found that PARP1-Ala762 displayed 57.2% of the activity of PARP1-Val762 for auto-poly(ADP-ribosyl)ation and 61.9% of the activity of PARP1-Val762 for trans-poly(ADP-ribosyl)ation of histone H1. The kinetic characterization revealed that the K(m) of PARP1-Ala762 was increased to a 1.2-fold of the K(m) of PARP1-Val762 for trans-poly(ADP-ribosyl)ation. Thus, the PARP1 Val762Ala polymorphism reduces the enzymatic activity of PARP1 by increasing K(m). This finding suggests that different levels of poly(ADP-ribosyl)ation by PARP1 might aid in understanding the cancer risk of carriers of the PARP1 Val762Ala polymorphism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17214964     DOI: 10.1016/j.bbrc.2006.12.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  54 in total

1.  Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Hongping Yu; Hongxia Ma; Ming Yin; Qingyi Wei
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

2.  Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat.

Authors:  Asgeir Brevik; Amit D Joshi; Román Corral; N Charlotte Onland-Moret; Kimberly D Siegmund; Loïc Le Marchand; John A Baron; Maria Elena Martinez; Robert W Haile; Dennis J Ahnen; Robert S Sandler; Peter Lance; Mariana C Stern
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-29       Impact factor: 4.254

3.  Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk.

Authors:  Tasha R Smith; Edward A Levine; Rita I Freimanis; Steven A Akman; Glenn O Allen; Kimberly N Hoang; Wen Liu-Mares; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2008-08-13       Impact factor: 4.944

4.  Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.

Authors:  Rui Gao; Douglas K Price; Tristan Sissung; Eddie Reed; William D Figg
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

5.  Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease.

Authors:  Hsin-Ping Liu; Wei-Yong Lin; Bor-Tsang Wu; Shu-Hsiang Liu; Wen-Fu Wang; Chon-Haw Tsai; Chun-Cheng Lee; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Correlation between PARP-1 Val762Ala polymorphism and the risk of lung cancer in a Chinese population.

Authors:  Ping Yu; Yun-Peng Liu; Jing-Dong Zhang; Xiu-Juan Qu; Bo Jin; Ye Zhang
Journal:  Tumour Biol       Date:  2014-09-02

7.  Analyzing structure-function relationships of artificial and cancer-associated PARP1 variants by reconstituting TALEN-generated HeLa PARP1 knock-out cells.

Authors:  Lisa Rank; Sebastian Veith; Eva C Gwosch; Janine Demgenski; Magdalena Ganz; Marjolijn C Jongmans; Christopher Vogel; Arthur Fischbach; Stefanie Buerger; Jan M F Fischer; Tabea Zubel; Anna Stier; Christina Renner; Michael Schmalz; Sascha Beneke; Marcus Groettrup; Roland P Kuiper; Alexander Bürkle; Elisa Ferrando-May; Aswin Mangerich
Journal:  Nucleic Acids Res       Date:  2016-09-29       Impact factor: 16.971

8.  Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines.

Authors:  T Zaremba; P Ketzer; M Cole; S Coulthard; E R Plummer; N J Curtin
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

Review 9.  Targeting poly(ADP-ribose) polymerase activity for cancer therapy.

Authors:  Frédérique Mégnin-Chanet; Marc A Bollet; Janet Hall
Journal:  Cell Mol Life Sci       Date:  2010-08-20       Impact factor: 9.261

10.  Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.

Authors:  Noel Pabalan; Ofelia Francisco-Pabalan; Hamdi Jarjanazi; Hong Li; Lillian Sung; Hilmi Ozcelik
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.